PARACELSIAN INC has a total of 21 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets measurement, machines and biotechnology are CALYPTE INC, LINCOLN MEMORIAL UNIV and INST OF CHILD HEALTH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | United States | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Canada | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Machines | |
#3 | Biotechnology | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Unspecified technologies | |
#3 | Measuring microorganism processes | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Babish John G | 11 |
#2 | Wheelock Geoffrey D | 10 |
#3 | Rininger Joseph | 6 |
#4 | Johnson Brian E | 6 |
#5 | Whiting Debra S | 6 |
#6 | Ma Xingfang | 4 |
#7 | Rininger Joseph A | 4 |
#8 | Ma Xinfang | 4 |
#9 | Chigurupati Padmasree | 4 |
#10 | Landes Bernard | 3 |
Publication | Filing date | Title |
---|---|---|
WO0003725A1 | Method for identifying and confirming consistent bio-functionality of natural compositions | |
US5833994A | Use of the AH receptor and AH receptor ligands to treat or prevent cytopathicity of viral infection | |
WO9704316A1 | Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases | |
US6127136A | Detection of dioxin-like compounds by detection of transformed Ah receptor/ARNT complex | |
AU4376396A | Use of andrographolide compounds to treat or prevent pathogenicity of diseases | |
EP0680609A1 | Products for measuring cell growth propensity and methods for their use. |